BioVie Inc (BIVI)
3.19
+0.01
(+0.31%)
USD |
NASDAQ |
Nov 15, 16:00
3.19
0.00 (0.00%)
After-Hours: 20:00
BioVie Research and Development Expense (TTM): 23.10M for June 30, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | 23.10M |
| March 31, 2024 | 29.35M |
| December 31, 2023 | 34.84M |
| September 30, 2023 | 35.41M |
| June 30, 2023 | 33.30M |
| March 31, 2023 | 30.87M |
| December 31, 2022 | 23.25M |
| September 30, 2022 | 20.93M |
| June 30, 2022 | 17.26M |
| March 31, 2022 | 11.91M |
| December 31, 2021 | 9.123M |
| September 30, 2021 | 5.348M |
| June 30, 2021 | 2.354M |
| March 31, 2021 | 1.976M |
| December 31, 2020 | 1.540M |
| September 30, 2020 | 0.9481M |
| June 30, 2020 | 1.189M |
| March 31, 2020 | 1.317M |
| December 31, 2019 | 1.296M |
| September 30, 2019 | 1.155M |
| June 30, 2019 | 1.008M |
| Date | Value |
|---|---|
| March 31, 2019 | 0.8281M |
| December 31, 2018 | 0.5427M |
| September 30, 2018 | 0.5235M |
| June 30, 2018 | 0.3709M |
| March 31, 2018 | 0.3656M |
| December 31, 2017 | 0.4392M |
| September 30, 2017 | 0.3809M |
| June 30, 2017 | 0.4664M |
| March 31, 2017 | 0.4138M |
| December 31, 2016 | 0.2937M |
| September 30, 2016 | 0.1652M |
| June 30, 2016 | 0.0379M |
| March 31, 2016 | 0.0008M |
| December 31, 2015 | 0.0008M |
| September 30, 2015 | 0.0008M |
| June 30, 2015 | 0.0042M |
| March 31, 2015 | 0.0034M |
| December 31, 2014 | 0.0228M |
| September 30, 2014 | 0.042M |
| June 30, 2014 | 0.05M |
| March 31, 2014 | 0.05M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
0.9481M
Minimum
Sep 2020
35.41M
Maximum
Sep 2023
15.02M
Average
11.91M
Median
Mar 2022
Research and Development Expense (TTM) Benchmarks
| Catalyst Pharmaceuticals Inc | 10.82M |
| MediciNova Inc | 5.873M |
| NovaBay Pharmaceuticals Inc | 0.064M |
| Palatin Technologies Inc | 22.40M |
| iBio Inc | 5.185M |